Search

Your search keyword '"Zanoni, L."' showing total 12 results
Start Over Author "Zanoni, L." Publisher elsevier bv
12 results on '"Zanoni, L."'

1. PO-1027 Radioiodine therapy guided by 124I-PET/CT in metastatic DTC: long-term follow-up data

Author

Lodi Rizzini, E., primary, Allegri, V., additional, Zanoni, L., additional, Tabacchi, E., additional, Laghi, V., additional, Strigari, L., additional, Repaci, A., additional, Scampoli, C., additional, Vallerossa, D., additional, Deraco, E., additional, Cavallini, L., additional, Bertini, F., additional, Cammelli, S., additional, Frezza, G.P., additional, Morganti, A.G., additional, Fanti, S., additional, and Monari, F., additional

Published
2021
Full Text
View/download PDF

2. PO-1023 Impact of 18F-FDG-PET/CT in the management of suspected RAI refractory DTC persistence/recurrence

Author

Lodi Rizzini, E., primary, Zanoni, L., additional, Tabacchi, E., additional, Repaci, A., additional, Scampoli, C., additional, Vallerossa, D., additional, Laghi, V., additional, Cavallini, L., additional, Razganiayeva, N., additional, Cardano, R., additional, Scirocco, E., additional, Cammelli, S., additional, Frezza, G.P., additional, Morganti, A.G., additional, Fanti, S., additional, and Monari, F., additional

Published
2021
Full Text
View/download PDF

5. Staging of Biochemically Relapsing Prostate Cancer Using the Positron Emission Tomography Tracer Fluciclovine F18

Author

Bach-Gansmo, T., primary, Nanni, C., additional, Nieh, P., additional, Zanoni, L., additional, Bogsrud, T., additional, Sletten, H., additional, Korsan, K., additional, Kieboom, J., additional, Chau, A., additional, Ward, P., additional, Willoch, F., additional, Goodman, M., additional, Fanti, S., additional, and Schuster, D.M., additional

Published
2016
Full Text
View/download PDF

6. 562 Accuracy of 18f-facbc (anti1-amino-3-18f-fluorocyclobutane-1-carboxylic acid) in prostate cancer relapse: Results of a prospective trial

Author

Pultrone, C.V., primary, Bianchi, L., additional, Brunocilla, E., additional, Fanti, S., additional, Nanni, C., additional, Zanoni, L., additional, Matti, A., additional, Borghesi, M., additional, Bravi, C., additional, Martorana, G., additional, Schiavina, R., additional, and Lorenzo, Bianchi, additional

Published
2016
Full Text
View/download PDF

8. 727 18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients

Author

Schiavina, R., primary, Brunocilla, E., additional, Nanni, C., additional, Borghesi, M., additional, Ceci, F., additional, Zanoni, L., additional, Vagnoni, V., additional, Della, Mora L., additional, Cevenini, M., additional, Del Prete, C., additional, Fanti, S., additional, and Martorana, G., additional

Published
2014
Full Text
View/download PDF

12. Hepatobiliary Scintigraphy in the Preoperative Evaluation of Potential Living Liver Donors

Author

Cinzia Pettinato, Matteo Ravaioli, Stefano Fanti, Matteo Serenari, Matteo Cescon, Chiara Bonatti, Alessandro Cucchetti, Lucia Zanoni, Federica Odaldi, A.D. Pinna, Serenari, M., Pettinato, C., Bonatti, C., Zanoni, L., Odaldi, F., Cucchetti, A., Ravaioli, M., Fanti, S., Pinna, A.D., and Cescon, M.

Subjects
Adult, Male, medicine.medical_specialty, medicine.medical_treatment, Computed tomography, Scintigraphy, Gastroenterology, Liver Function Tests, Internal medicine, Living Donors, medicine, Graft selection, Humans, Radionuclide Imaging, Aged, Transplantation, medicine.diagnostic_test, business.industry, Liver failure, Middle Aged, Liver Transplantation, Treatment Outcome, Liver, Liver donors, Female, Surgery, Liver function, Hepatectomy, business, Major hepatectomy
Abstract

Background Graft selection strategy in living donor liver transplantation (LDLT) is usually multifactorial, but special attention is paid to the determination of donor liver volumes to minimize any risk of posthepatectomy liver failure (PHLF). Hepatobiliary scintigraphy (HBS) with single-photon-emission computed tomography allows for the measurement of total and future liver remnant function (FLR-F) and has been shown to predict the risk of PHLF more accurately than liver volumetry. Methods Since November 2016, HBS has been performed at our Institution in every candidate to major hepatectomy, including potential living liver donors. Results Thirty-seven consecutive patients were submitted to HBS, of whom 7 were potential living liver donors. After completed hepatectomy (n = 27), the median FLR-F of patients who developed PHLF (n = 9) was 1.72%/min/m2 (range 1.40–2.78) compared to that of patients who did not (n = 18), which was 4.02%/min/m2 (range 1.15–12.08). Three donors underwent operations (1 right hepatectomy and 2 left hepatectomies). In the only donor who developed PHLF, the FLR accounted for the 37% of the total liver volume, whereas the FLR represented only the 31% of the total liver function (TL-F = 11.29%/min) with a resulting FLR-F of 2.05%/min/m2. Conclusions The present study suggests that a non-invasive low-cost exam such as HBS may be a promising tool to predict PHLF not only in neoplastic patients but also to evaluate potential living donors. Larger studies are needed to draw any conclusion regarding the benefits of HBS in the living liver donor workup.

Published
2019
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results